# AEON Biopharma, Inc.: Form S-1, filed Jul 8, 2026

- Company: [AEON Biopharma, Inc.](/companies/aeon.md) (CIK 1837607)
- Form: S-1
- Filed: 2026-07-08
- Accepted by EDGAR: Jul 8, 2026, 17:26 ET
- Period: not reported
- Accession: 0001104659-26-081860
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1837607/000110465926081860/tm2615250-3_s1.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1837607/000110465926081860/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1837607/000110465926081860/tm2615250-3_s1.htm

Filed Jul 8, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-081860. Last ingested by Listed: Nov 3, 2026, 09:04 ET. No prices; not investment advice.